Poole Sandra is a director of Travere Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Travere Therapeutics, Inc.
19 May 23
4
Travere Therapeutics, Inc.
12 May 22
4
Travere Therapeutics, Inc.
18 May 21
4
Retrophin, Inc.
19 May 20
4
Retrophin, Inc.
15 May 19
3
Retrophin, Inc.
15 May 19
4/A
LogicBio Therapeutics, Inc.
24 Oct 18
4
LogicBio Therapeutics, Inc.
22 Oct 18
3
LogicBio Therapeutics, Inc.
18 Oct 18
4
IMMUNOGEN INC
20 Oct 16
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 May 23 | TVTX Travere Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 4,500 | 0.00 | 17,000 |
17 May 23 | TVTX Travere Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 17.11 | 13,500 | 230.99 k | 13,500 |